ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00932451
Brief Title: An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

First Submitted : June 30, 2009
First Submitted that Met QC Criteria : July 2, 2009
First Posted : July 3, 2009 (Estimate)

Results First Submitted : March 14, 2016
Results First Submitted that Met QC Criteria : April 28, 2016
Results First Posted : June 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 17, 2016
Last Update Posted : January 13, 2017 (Estimate)